Hikma Pharmaceuticals Share News (HIK)

BUZZ-Hikma: Keeps guidance intact despite revenue drop

** Hikma rises as much as 5 pct to 2520 pence after co maintains FY guidance, making them the second highest FTSE-100 gainers ** Shares rise to highest in almost 6 months, with 70 pct of avg 30-day volumes going through in first 3 hours ** Stock is also number 3 gainer on Europe's ben

WINNERS & LOSERS SUMMARY: Admiral And Hikma Up But Glencore Plunges

TOP NEWS SUMMARY: Glencore Shares Hit Record Low As Earnings Slump

LONDON MARKET MID-MORNING: Glencore And China Undermine Sentiment

UPDATE: Hikma Keeps Guidance, Strong Dollar Hampers First Half Profit

Hikma reiterates guidance as currency headwinds weigh on interims

(ShareCast News) - Hikma Pharmaceuticals reiterated its full-year guidance, although strong currency headwinds weighed on its interim pre-tax profit. The FTSE 100 group said it expected full-year revenue to grow approximately 6% year-on-year at constant currency or around 2% at actual exchange rates

LONDON BRIEFING: Admiral And Hikma In Favour As Glencore Shares Fall

Hikma Reiterates Guidance As Strong Dollar Hampers First Half Profit

LONDON MARKET EARLY CALL: Greek Bailout Votes, US Fed Minutes In Focus

Earnings, Trading Statements Calendar - Week Ahead

LONDON MARKET CLOSE: FTSE 100 Dragged Down By Miners As Pound Gains

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead